688062 Mabwell
- 18.25
- -0.09-0.49%
Mabwell News
Maiwei Biotech: Maiwei Biotech voluntarily disclosed the announcement that 9MW2821 combined with treprimab was included in the public list of breakthrough treatment varieties for first-line treatment of urothelial cancer
Maiwei Biotech voluntarily disclosed an announcement on the inclusion of 9MW2821 and treprilizumab in the first-line treatment of urothelial cancer in the public list of breakthrough treatment varieties
Maiwei Biotech: Announcement on the submission of an application for the issuance and listing of H shares to the Hong Kong Stock Exchange and publication of application materials
Maiwei Biotech: Maiwei Biotech\'s announcement on opening a special fund raising account and signing a tripartite supervisory agreement for fund raising special account storage
Announcement of Maiwei Biotech\'s submission of an application for the issuance and listing of H shares to the Hong Kong Stock Exchange and publication of application materials
Maiwei Biotech Investor Relations Activity Record List (December 1, 2024)
Maiwei Biotech: “Management System for Related (Connected) Transactions with Maiwei (Shanghai) Biotechnology Co., Ltd.” (Draft)
Maiwei Biotech: Announcement of Resolutions of the 15th Meeting of the 2nd Board of Directors of Maiwei Biotech
Maiwei Biotech: Miwei Biotech\'s indicative announcement on matters relating to the company\'s planning to issue H shares and go public on the Hong Kong Stock Exchange Limited
Maiwei Biotech: Resolutions of the 2nd Meeting of the 2nd Special Meeting of Independent Directors of Maiwei Biotech\'s Board of Directors
Maiwei Biotech: “Maiwei (Shanghai) Biotechnology Co., Ltd. Shareholder Communications Policy” (draft)
Maiwei Biotech: Review Opinions of the 2nd Meeting of the Nomination Committee of the 2nd Maiwei Biotech Board of Directors
Maiwei Biology: “Maiwei (Shanghai) Biotechnology Co., Ltd. Director Nomination Policy” (draft)
Maiwei Biotech: Announcement of Resolutions of the 14th Meeting of the 2nd Supervisory Board of Maiwei Biotech
Maiwei Biotech: Maiwei Biotech\'s announcement on formulating part of the company\'s governance system
Maiwei Biology: “Constitution of Maiwei (Shanghai) Biotechnology Co., Ltd.” (draft)
Maiwei Biotech: “Procedure for Shareholders of Maiwei (Shanghai) Biotechnology Co., Ltd. to nominate candidates for election as directors” (draft)
Maiwei Biotech: Maiwei Biotech\'s announcement on expected daily related transactions in 2025
Maiwei Biotech: Opinions of Haitong Securities Co., Ltd. on the daily related transactions expected by Maiwei (Shanghai) Biotechnology Co., Ltd. in 2025
Maiwei Biotech: Inspection opinions of Haitong Securities Co., Ltd. on adding implementing entities and establishing new special fund-raising accounts for some fund-raising projects of Maiwei (Shanghai) Biotechnology Co., Ltd.
No Data